BTC $79,410.00 -0.54%
ETH $2,498.25 +0.21%
BNB $746.05 -0.72%
XRP $1.41 -0.66%
SOL $105.20 -1.04%
TRX $0.3353 +0.08%
DOGE $0.0908 +1.47%
ADA $0.2227 +1.79%
BCH $260.47 +0.86%
LINK $13.21 +7.44%
HYPE $87.63 -1.35%
AAVE $133.29 -1.46%
SUI $0.8244 +3.71%
XLM $0.1926 +3.67%
ZEC $1,179.14 -0.89%
BTC $79,410.00 -0.54%
ETH $2,498.25 +0.21%
BNB $746.05 -0.72%
XRP $1.41 -0.66%
SOL $105.20 -1.04%
TRX $0.3353 +0.08%
DOGE $0.0908 +1.47%
ADA $0.2227 +1.79%
BCH $260.47 +0.86%
LINK $13.21 +7.44%
HYPE $87.63 -1.35%
AAVE $133.29 -1.46%
SUI $0.8244 +3.71%
XLM $0.1926 +3.67%
ZEC $1,179.14 -0.89%

The publicly traded company Applied DNA Sciences disclosed that its initial BNB holdings are valued at over 17 million dollars

2025-10-22 20:20:58

ChainCatcher news, according to businesswire, biotechnology company Applied DNA Sciences, Inc. (NASDAQ: APDN) announced that it has completed the previously announced private equity investment (PIPE) financing led by institutional DeFi and TradFi investors, with an initial BNB holding valued at over $17 million.

The PIPE brought the company approximately $27 million in total proceeds, with the potential to gain an additional total of up to $31 million in the future through the exercise of warrants. The total proceeds from the PIPE transaction include $15.3 million in cash and stablecoins, as well as $11.71 million in OBNB trust units.

The company has received a total of 435,638 trust units, which represent underlying ownership of 10,647 BNB tokens. The company also announced today that it has additionally purchased 4,908 BNB tokens, estimated to be worth $5.3 million as of 10:00 PM Eastern Time on October 20, 2025.

app_icon
ChainCatcher Building the Web3 world with innovations.